Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1522282 (
EMT
)
2,868
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SUZ12
is a core component of the polycomb repressive complex 2 (PRC2), which could silence gene transcription by generating trimethylation on lysine 27 residue of histone H3 (H3K27Me3). Meanwhile,
SUZ12
has been found to be overexpressed in multiple cancers; however, the clinical significance and molecular mechanisms of
SUZ12
controlling gastric cancer cell proliferation and metastasis are unclear. In this study, we found that
SUZ12
expression was significantly increased in 64 gastric tumor tissues compared with normal tissues. Additionally,
SUZ12
expression was associated with pathological stage, metastasis distance, and shorter overall survival of gastric cancer patients. Knockdown of
SUZ12
expression impaired cell proliferation and invasion in vitro, leading to the inhibition of metastasis in vivo. Upregulation of
SUZ12
was found to play a key role in gastric cancer cell proliferation and metastasis through the regulation of
EMT
and KLF2 expression.
...
PMID:SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin. 2567 9